peptide-solutions
Dual GLP-1 / glucagon receptor agonist (10 mg per vial)
Research Compound
Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.

Survodutide is an investigational dual agonist of the GLP-1 and glucagon receptors. Research explores its effects on energy expenditure, hepatic fat metabolism, and weight regulation.
Compound Specifications
Select the amount contained in each vial.
Choose one vial, or choose a kit with 10 units priced as 8.
Amount per vial: 10mg
Scientific Documentation
Detailed research information, pharmacological profile, and handling specifications
Concurrent activation of GLP-1R (insulinotropic, satiety) and GcgR (energy expenditure, hepatic lipid handling) creates a complementary metabolic profile distinct from GLP-1 mono-agonism.
Verified Buyer Reviews
Loading reviews...
This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.
Other research peptides you may be interested in

Triple-action GLP-1/GIP/Glucagon receptor agonist
from $125

Dual GLP-1/GIP receptor agonist for metabolic research
from $109

GLP-1 receptor agonist for metabolic research
from $83